To evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells transplantation in patients with bronchopulmonary dysplasia
The purpose of this study is to evaluate the safety and effectiveness of human umbilical cord mesenchymal stem cells in 10 patients with bronchopulmonary dysplasia at Vinmec International Hospital, Hanoi, Vietnam
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Transplantation of umbilical cord mesenchymal stem cells
Vinmec Research Institute of Stem Cell and Gene Technology
Hanoi, Vietnam
Adverse events and serious adverse events
Incidence of the adverse events or serious adverse events after transplantation
Time frame: during 9 months post treatment
The proportion of patients win from oxygen
To identify the proportion of patient with Bronchopulmonary Dysplasia win from oxygen after stem cell transplantation.
Time frame: during 9 months post treatment
The lung fibrosis
Changes of the lung fibrosis on chest CT at 6 months compared with baseline
Time frame: at 6 months post treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.